Biomerieux S A Unsp/Adr (BMXXY) Q4 2024 Earnings Call

Investor webinar replay

Replay transcript excerpt

Good day and welcome to the BioMario fourth quarter sales and full year 2024 results conference call. Today's conference is being recorded. At this time, I'd like to turn the conference over to Emeric Fichet. Please go ahead. Thanks. Good afternoon, everyone, and thank you for joining us to review the BioMario 2024 financial performance. I'm online with Pierre Boulu, CEO, together with Guillaume Bouhour, CFO. Before ending the call over to Pierre and Guillaume, please note that this conference call will include forward-looking statements that may change or be modified due to uncertainties and risks related to the company's environment. Accordingly, we cannot give any assurance as to whether we will achieve this objective. I also remind you that today's call is being recorded and that a replay will be available on our website. I will now hand the call over to Pierre, and then we will open the call to discussion and questions. Pierre, it's to you. Thank you, Aymeric. Good day, everyone. Good morning. So let me start with a review of our 2024 business. So first of all, as you know, this is the first year of delivery of the Go28 plan that we disclosed to the market almost a year ago. Also, first full year for me as a CEO for the company. And I'm very glad to report back that on all four dimensions of our Go28 plan, we are either at target or above the target. So in terms of sales growth, we have a 7% sales growth compounded growth rate over the next five years. We've achieved 10.3%. In terms of profitability improvements, we've increased our profits by 20% at concentration rates. In terms of engagement for our teams, we have actually reached our target, which is to be in the top quarter in terms of engagement of our employees. And finally, the responsibility dimension of...